Azitra
NYSE: AZTRFarmington, US · Founded 2014 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
AM
Azim MunivarNamed on SEC filing
Board
SR
TW
Investors · 2
Reported raises · per SEC filings
Form D private placements$32.1M disclosed across 6 rounds · 2017–2022
▶$4.3MraisedOct 2022 · 5 investors · BiotechnologyRule 506(b)
▶$4.3MraisedOct 2022 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- STELLA ROBERTSONDirector
- FRANCISCO SALVAExecutive Officer, Director
- TRAVIS WHITFILLDirector
- NAVEEN KRISHANDirector
- ANDREW MCCLARYDirector
- Offering amount
- $4.5M
- Amount sold
- $4.3M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedJan 2021 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedJan 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Travis WhitfillDirector
- Lucio IannoneDirector
- Andrew McClaryDirector
- Stella RobertsonDirector
- Richard AndrewsExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1M
- First sale
- Jan 2021
- Incorporated
- Corporation, Connecticut
- Federal exemptions
- 06b
▶$17MraisedSep 2020 · 8 investors · BiotechnologyRule 506(b)
▶$17MraisedSep 2020 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cain McClaryDirector
- Travis WhitfillDirector
- Stella RobertsonDirector
- Lucio IannoneDirector
- Ricahrd AndrewsExecutive Officer, Director
- Offering amount
- $17M
- Amount sold
- $17M
- First sale
- Sep 2020
- Incorporated
- Corporation, Connecticut
- Federal exemptions
- 06b
▶$4.7MraisedMar 2019 · 5 investors · BiotechnologyRule 506(b)
▶$4.7MraisedMar 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard AndrewsExecutive Officer, Director
- Stella RobertsonDirector
- Travis WhitfillDirector
- Andrew McClaryDirector
- Offering amount
- $17.3M
- Amount sold
- $4.7M
- First sale
- Feb 2019
- Incorporated
- Corporation, Connecticut, 2014
- Federal exemptions
- 06b
▶$2.1MraisedApr 2018 · 5 investors · BiotechnologyRule 506(b)
▶$2.1MraisedApr 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Travis WhitfillExecutive Officer, Director
- Richard AndrewsExecutive Officer, Director, Promoter
- Daniel WagnerDirector
- Azim MunivarDirector
- Stella RobertsonDirector
- Offering amount
- $2.5M
- Amount sold
- $2.1M
- First sale
- Apr 2018
- Incorporated
- Corporation, Connecticut, 2014
- Federal exemptions
- 06b
▶$2.9MraisedMar 2017 · 3 investors · BiotechnologyRule 506(b)
▶$2.9MraisedMar 2017 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Azim MunivarExecutive Officer, Director, Promoter
- Stella RobertsonDirector
- Travis WhitfillExecutive Officer, Director, Promoter
- Offering amount
- $3.7M
- Amount sold
- $2.9M
- First sale
- Mar 2017
- Incorporated
- Corporation, Connecticut, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Robinhood14 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha10 shared keywordsSeeking Alpha is a financial research platform that provides stock analysis, investment tools, and market coverage across asset classes to investors. The platform aggregates research from thousands of analysts and investors, offering ratings, articles, and investment ideas.
IQVIA10 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Stocktwits10 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
Public9 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
Companies competing with Azitra for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase II | 2019 | $719.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $225K |
| National Science Foundation | Phase ISTTR | 2017 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2016 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Azitra's investors?
- Azitra's investors include Bios Partners, KdT Ventures.
- How much funding has Azitra raised?
- Azitra has disclosed $32.1M raised across 6 rounds.
- Where is Azitra headquartered?
- Azitra is headquartered in Farmington, US.